Table 2 Characteristics of participants according to stroke and CAS status
From: Elevated RANTES levels are associated with increased risk of cerebral atherosclerotic stenosis
Variables | Non-AIS (n = 65) | AIS (n = 62) | p-value | Non-AIS | AIS | ||||
|---|---|---|---|---|---|---|---|---|---|
Non-CAS (n = 26) | CAS (n = 30) | p-value | Non-CAS (n = 23) | CAS (n = 38) | p-value | ||||
TNF-α, pg/ml | 5.42 ± 0.23 | 5.56 ± 0.21 | 0.654 | 5.70 ± 0.34 | 5.24 ± 0.30 | 0.325 | 5.50 ± 0.38 | 5.6 ± 0.26 | 0.823 |
IL-6, pg/ml | 3.29 ± 0.18 | 3.6 ± 0.21 | 0.253 | 3.26 ± 0.23 | 3.30 ± 0.26 | 0.890 | 3.20 ± 0.36 | 3.85 ± 0.26 | 0.146 |
MMP-9, ng/ml | 27.61 ± 4.89 | 35.09 ± 5.93 | 0.331 | 25.64 ± 4.83 | 28.88 ± 7.44 | 0.749 | 31.09 ± 9.38 | 37.45 ± 7.69 | 0.609 |
MMP-1, ng/ml | 1.80 ± 0.15 | 3.03 ± 0.39 | 0.003 | 1.95 ± 0.25 | 1.71 ± 0.19 | 0.446 | 2.41 ± 0.36 | 3.40 ± 0.58 | 0.226 |
IP-10, pg/ml | 31.98 ± 2.11 | 26.96 ± 2.19 | 0.101 | 26.29 ± 2.25 | 35.88 ± 3.08 | 0.025 | 28.16 ± 3.94 | 26.28 ± 2.63 | 0.684 |
RANTES, ng/ml | 12.12 ± 0.55 | 13.89 ± 0.60 | 0.031 | 10.54 ± 0.80 | 13.20 ± 0.71 | 0.016 | 11.96 ± 0.87 | 15.03 ± 0.75 | 0.011 |
VEGF, pg/ml | 51.57 ± 5.55 | 52.16 ± 4.57 | 0.935 | 52.28 ± 7.04 | 51.10 ± 8.05 | 0.918 | 52.25 ± 5.33 | 52.11 ± 6.60 | 0.988 |
IL-23, pg/ml | 89.28 ± 5.00 | 87.96 ± 3.54 | 0.830 | 95.05 ± 11.17 | 85.49 ± 3.89 | 0.354 | 77.86 ± 5.22 | 93.91 ± 4.48 | 0.027 |